innoscripta SE (ISIN: DE000A40QVM8) has launched operations in the United Kingdom, marking the next phase of its international expansion following a successful entry into France earlier this year. The German software company has established a dedicated local sales team and already secured its first UK customer—a software firm with annual revenues in the mid-double-digit million euro range.
The customer has selected innoscripta's SaaS platform Clusterix, which has been fully adapted to UK regulatory requirements, to support its R&D tax relief claims. Clusterix enables companies to systematically capture R&D projects, working hours and eligible costs while creating a comprehensive, audit-ready documentation trail. This capability is increasingly critical as HM Revenue & Customs (HMRC) has substantially tightened its documentation and compliance requirements for R&D tax relief claims in recent years.
The UK represents a significant opportunity for innoscripta. With annual R&D tax reliefs of approximately EUR 8.7 billion (around 0.3% of GDP), the UK is Europe's second-largest R&D tax incentive market after France and roughly seven times larger than Germany. The company plans to significantly expand both its UK sales organization and customer base by the end of the year, with several additional customer engagements already at an advanced stage of negotiations.
The expansion comes as businesses face increasing scrutiny from HMRC on R&D claims. Clusterix's audit-ready documentation helps companies meet these stricter requirements, reducing the risk of rejected claims or penalties. For the UK's innovation-driven industries, this could mean more efficient management of R&D tax credits, which are a vital source of funding for research-intensive companies.
innoscripta's move into the UK follows its market entry into France, announced in a news release dated April 15, 2026. The company's international growth strategy targets Europe's largest R&D tax incentive markets, where its platform can help businesses streamline compliance and maximize claims.
innoscripta SE offers Clusterix, a scalable software platform for the structured organization and management of research and development activities. Companies use Clusterix to efficiently manage innovation projects, digitize internal processes, and make their R&D activities transparent and scalable.
For more information, view the original release on NewMediaWire.
